Patents Assigned to Interzyne Technologies, Inc.
  • Patent number: 10143689
    Abstract: The present invention provides SN-38 compositions for treating cancer.
    Type: Grant
    Filed: February 8, 2018
    Date of Patent: December 4, 2018
    Assignee: Interzyne Technologies, Inc.
    Inventors: Kevin N. Sill, Adam Carie